• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Proposal of Tumor Size as an Index for Biologic Factor of Resectability Status of Pancreatic Ductal Adenocarcinoma.

作者信息

Miyata Yoichi, Kishi Yoji

机构信息

Department of Surgery, Asahi General Hospital, Chiba, Japan.

Department of Surgery, National Defense Medical College Hospital, Saitama, Japan.

出版信息

Ann Surg Oncol. 2023 Dec;30(13):8644-8645. doi: 10.1245/s10434-023-14261-1. Epub 2023 Sep 10.

DOI:10.1245/s10434-023-14261-1
PMID:37689609
Abstract
摘要

相似文献

1
ASO Author Reflections: Proposal of Tumor Size as an Index for Biologic Factor of Resectability Status of Pancreatic Ductal Adenocarcinoma.
Ann Surg Oncol. 2023 Dec;30(13):8644-8645. doi: 10.1245/s10434-023-14261-1. Epub 2023 Sep 10.
2
ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.ASO作者反思：胰腺导管腺癌新辅助化疗后的预后指数（PINC）作为新型肿瘤消退分级系统
Ann Surg Oncol. 2022 Jun;29(6):3503. doi: 10.1245/s10434-022-11461-z. Epub 2022 Feb 20.
3
ASO Author Reflections: Prognostic Value of Tumor Deposits in Resected Pancreatic Ductal Adenocarcinoma.ASO作者反思：肿瘤沉积物在切除的胰腺导管腺癌中的预后价值。
Ann Surg Oncol. 2023 May;30(5):3045. doi: 10.1245/s10434-023-13109-y. Epub 2023 Jan 25.
4
ASO Author Reflections: Accurate Evaluation of Malignant Potential in Pancreatic Ductal Adenocarcinoma Using DUPAN-2 Level.ASO作者反思：利用DUPAN-2水平准确评估胰腺导管腺癌的恶性潜能
Ann Surg Oncol. 2024 Jul;31(7):4697. doi: 10.1245/s10434-024-15272-2. Epub 2024 May 13.
5
ASO Author Reflections: Relationship Between Sarcopenia, Patient Prognosis, and Tumor-Infiltrating T Cells in Pancreatic Ductal Adenocarcinoma.ASO作者反思：胰腺导管腺癌中肌肉减少症、患者预后与肿瘤浸润性T细胞之间的关系
Ann Surg Oncol. 2023 Sep;30(9):5788-5789. doi: 10.1245/s10434-023-13575-4. Epub 2023 May 11.
6
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.ASO作者反思：部位重要吗？肿瘤位置对切除的胰腺导管腺癌病理特征、复发及生存的影响
Ann Surg Oncol. 2020 Oct;27(10):3913-3914. doi: 10.1245/s10434-020-08572-w. Epub 2020 May 12.
7
ASO Author Reflections: Constructed Scoring System Using TP53 and SMAD4 Mutations Combined with Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma.ASO作者反思：利用TP53和SMAD4突变联合糖类抗原19-9构建胰腺导管腺癌评分系统
Ann Surg Oncol. 2022 Aug;29(8):5020-5021. doi: 10.1245/s10434-022-11735-6. Epub 2022 May 9.
8
ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.ASO作者反思：体尾部胰腺导管腺癌中脾脏动脉放射学受累的预后影响
Ann Surg Oncol. 2022 Oct;29(11):7059-7060. doi: 10.1245/s10434-022-11957-8. Epub 2022 Jun 1.
9
ASO Author Reflections: A Novel Mechanism of Anticancer Effect of Skeletal Muscle-Derived Irisin in Pancreatic Ductal Adenocarcinoma.ASO作者反思：骨骼肌来源的鸢尾素在胰腺导管腺癌中抗癌作用的新机制
Ann Surg Oncol. 2024 Aug;31(8):5000-5001. doi: 10.1245/s10434-024-15349-y. Epub 2024 May 9.
10
ASO Author Reflections: Timing of Systemic Therapy and Postoperative Morbidity in Resectable Pancreatic Ductal Adenocarcinoma and Distal Cholangiocarcinoma.ASO作者反思：可切除胰腺导管腺癌和远端胆管癌全身治疗的时机与术后发病率
Ann Surg Oncol. 2023 Aug;30(8):5035. doi: 10.1245/s10434-023-13581-6. Epub 2023 May 13.

本文引用的文献

1
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.2017 年国际胰腺导管腺癌边界可切除定义和标准的共识。
Pancreatology. 2018 Jan;18(1):2-11. doi: 10.1016/j.pan.2017.11.011. Epub 2017 Nov 22.
2
National Comprehensive Cancer Network Resectability Status for Pancreatic Carcinoma Predicts Overall Survival.美国国立综合癌症网络（National Comprehensive Cancer Network）的胰腺癌可切除性状态可预测总生存期。
World J Surg. 2015 Sep;39(9):2306-14. doi: 10.1007/s00268-015-3096-3.